These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31340753)

  • 1. A plea for taking all available clinical information into account when assessing the predictive value of omics data.
    Volkmann A; De Bin R; Sauerbrei W; Boulesteix AL
    BMC Med Res Methodol; 2019 Jul; 19(1):162. PubMed ID: 31340753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials.
    Ternès N; Rotolo F; Michiels S
    BMC Med Res Methodol; 2017 May; 17(1):83. PubMed ID: 28532387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dimensional Cox models: the choice of penalty as part of the model building process.
    Benner A; Zucknick M; Hielscher T; Ittrich C; Mansmann U
    Biom J; 2010 Feb; 52(1):50-69. PubMed ID: 20166132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer evaluation of gene expression and somatic alteration data for cancer prognosis prediction.
    Zheng X; Amos CI; Frost HR
    BMC Cancer; 2021 Sep; 21(1):1053. PubMed ID: 34563154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the prediction ability of survival models based on both clinical and omics data: two case studies.
    De Bin R; Sauerbrei W; Boulesteix AL
    Stat Med; 2014 Dec; 33(30):5310-29. PubMed ID: 25042390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
    Tong L; Mitchel J; Chatlin K; Wang MD
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of clinically relevant features in hypertensive patients using penalized regression: a case study of cardiovascular events.
    Garcia-Carretero R; Barquero-Perez O; Mora-Jimenez I; Soguero-Ruiz C; Goya-Esteban R; Ramos-Lopez J
    Med Biol Eng Comput; 2019 Sep; 57(9):2011-2026. PubMed ID: 31346948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer.
    Malik V; Kalakoti Y; Sundar D
    BMC Genomics; 2021 Mar; 22(1):214. PubMed ID: 33761889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Object-oriented regression for building predictive models with high dimensional omics data from translational studies.
    Zhao LP; Bolouri H
    J Biomed Inform; 2016 Apr; 60():431-45. PubMed ID: 26972839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priority-Lasso: a simple hierarchical approach to the prediction of clinical outcome using multi-omics data.
    Klau S; Jurinovic V; Hornung R; Herold T; Boulesteix AL
    BMC Bioinformatics; 2018 Sep; 19(1):322. PubMed ID: 30208855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
    Paciorek CJ; Liu Y;
    Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale benchmark study of survival prediction methods using multi-omics data.
    Herrmann M; Probst P; Hornung R; Jurinovic V; Boulesteix AL
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32823283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added predictive value of omics data: specific issues related to validation illustrated by two case studies.
    De Bin R; Herold T; Boulesteix AL
    BMC Med Res Methodol; 2014 Oct; 14():117. PubMed ID: 25352096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boosting the discriminatory power of sparse survival models via optimization of the concordance index and stability selection.
    Mayr A; Hofner B; Schmid M
    BMC Bioinformatics; 2016 Jul; 17():288. PubMed ID: 27444890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression models.
    Zemmour C; Bertucci F; Finetti P; Chetrit B; Birnbaum D; Filleron T; Boher JM
    Cancer Inform; 2015; 14(Suppl 2):129-38. PubMed ID: 25983547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCC-AUC: an AUC optimization method to identify multi-biomarker panel for cancer prognosis from genomic and clinical data.
    Zou M; Liu Z; Zhang XS; Wang Y
    Bioinformatics; 2015 Oct; 31(20):3330-8. PubMed ID: 26092859
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.